Drug Safety
Conditions
Brief summary
The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.
Interventions
DRUGHyaluronidase
Sponsors
Northwestern University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Age 18 and over * The subjects are in good health * The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator
Exclusion criteria
* Under 18 years of age * Pregnancy or Lactation * Subjects who are unable to understand the protocol or to give informed consent * Subjects with mental illness * Recent Accutane use in the past 6 months * Subjects prone to hypertrophic and keloidal scarring * Subjects with tattoos and/or scars on upper medial arms (the treatment area) * Subjects with known hypersensitivity to hyaluronic acid
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dose of hyaluronidase injected until the filler is no longer detectable | 2 weeks |
Countries
United States
Outcome results
None listed